Skip to content

The effectiveness of Calcarea Phosphorica 6X in cases of Vitamin D deficiency or insufficiency in comparison to Individualised Homoeopathic treatment

The comparative effectiveness between Individualised Homoeopathic Medicines and Calcarea Phosphorica 6X in cases of Vitamin D deficiency or insufficiency; An open-label, randomised clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079767
Enrollment
60
Registered
2025-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E559- Vitamin D deficiency, unspecified

Interventions

Intervention1: Calcarea Phosphorica 6x: Calcarea Phosphorica will be prescribed in 6X potency, 4 tablets, thrice daily (TDS) for a period of 3 months. Control Intervention1: Individualised Homoeopathi

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with serum Vitamin D-25(OH) less than 30ng per mL Patients of all religions and races irrespective of socioeconomic status Patients willing to take part in the study and for regular follow ups Patients who are willing to fill the respective consent forms

Exclusion criteria

Exclusion criteria: Patients with severe hepatic and renal diseases Patients with serum Vitamin D-25(OH) less than 5ng per mL Pregnant and lactating women. Patients not willing to take part in study and regular follow ups. Patients having any terminal disease condition. Patients taking Vitamin D supplements or allopathic medicines for Vitamin D deficiency. Patients taking Homoeopathic medicines within the last one month.

Design outcomes

Primary

MeasureTime frame
Serum Vitamin D-25(OH) testing using Chemiluminescence Immunoassay (CLIA) techniqueTimepoint: at baseline and after a period of 3 months

Secondary

MeasureTime frame
Serum Calcium testingTimepoint: at baseline and after a period of 3 months

Countries

India

Contacts

Public ContactProf Dr PRASANTA RATH

National Institute of Homoeopathy

drprasantarath09@gmail.com8420924836

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026